DGAP-News: Apricus Biosciences Announces Allowance of a NexACT(R) Technology-Based Patent in Europe for the Manufacture of DDAIP
Apricus Biosciences, Inc.
22.03.2012 12:00
—————————————————————————
SAN DIEGO, 2012-03-22 12:00 CET (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
(http://www.apricusbio.com), announced today that the European Patent Office
(–EPO–) has issued an official decision to allow the Company–s patent
application entitled, –Method for the Manufacture of Dodecyl
2-(N,N-Dimenthylamino)-Propionate.–
